| Breast Cancer and the Effects of Chemotherapy with or without Bevacizumab
|
This trial is studying six different chemotherapy regimens to compare how well they work with or without bevacizumab in treating women with stage I, stage II, or stage IIIA breast cancer that can be removed by surgery. |
| |
| Breast Cancer and the Effects of Combination Chemotherapy
|
This trial is studying cyclophosphamide and doxorubicin to see how well they work compared to paclitaxel in treating women with invasive breast cancer. |
| |
| Breast Cancer and the Effects of Doxorubicin, Cyclophosphamide, and Paclitaxel with or Without Bevacizumab
|
Drugs used in chemotherapy, such as doxorubicin, cyclophosphamide, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. |
| |
| Breast Cancer and the Effects of Letrozole
|
This trial is studying letrozole to see how well it works compared with a placebo in treating postmenopausal women who have received hormone therapy for hormone receptor-positive breast cancer. |
| |
| Breast Cancer and the Effects of Neratinib vs Lapatinib Plus Capecitabine
|
This is a study of an experimental drug (neratinib) versus a combination of drugs (lapatinib and capecitabine) in women who have erbB-2 (HER-2) positive metastatic or locally advanced breast cancer. The goal of this study is to compare the two regimens in shrinking tumors and extending the lives of women with erbB2 (HER2) positive breast cancer. The study will also compare the safety of the two regimens and to compare quality of life of patients taking the two regimens. |
| |
| Breast Cancer and the Effects of Paclitaxel plus Trastuzumab or Lapatinib
|
This trial is studying whether breast cancer tumors respond to combined chemotherapy of AC followed by paclitaxel plus trastuzumab or lapatinib or both given before surgery to patients with HER2-positive breast cancer. |
| |
| Ductal carcinoma and the effects of radiation therapy
|
This trial is studying whole breast radiation therapy to see how well it works compared to partial breast radiation therapy in treating women who have undergone surgery for ductal carcinoma in situ or stage I or stage II breast cancer. |
| |
| Node-negative breast cancer and the effect of hormone therapy and chemotherapy
|
This trial is comparing the disease-free survival of women with previously resected axillary-node negative breast cancer treated with adjuvant combination chemotherapy and hormonal therapy vs. adjuvant hormonal therapy alone. |
| |
| Relapsed Breast Cancer Resection and the Effects of Adjuvant Chemotherapy
|
Determines the effectiveness of adjuvant chemotherapy in treating women who have undergone resection for local and/or regional relapsed breast cancer. |
| |